To AI or not to AI? That’s the question…
Is AI helpful to all biotechs? When to apply it, how to apply it, do you know what it is?
FACILITATED BY
KEVIN COX | Chair | Biorelate
PANELLISTS
JUSTIN BRYANS | Chief Scientific Officer (Early Discovery) | Charles River Laboratories
MARK HUGHES | Vice President of Sales & Marketing | Biorelate
DANIEL VERES| Chief Scientific Officer & Co-Founder | Turbine
DEAN PLUMBLEY | CTO and Head of AI | CoSyne Therapeutics
JOSEPH DAY|Business Development (Data/AI) | Cancer Research UK